OTTAWA, ON, March 31, 2026 /PRNewswire/ – On April 8th, Claigan will present a webinar focusing on a major update to substances in scope of the EU Medical Device Regulation (EU MDR). To maintain EU market access by 2028, device registrations must account for forty (40) new Carcinogens,…